Literature DB >> 1908002

Cytokines and the pathogenesis of neuroborreliosis: Borrelia burgdorferi induces glioma cells to secrete interleukin-6.

G S Habicht1, L I Katona, J L Benach.   

Abstract

Lyme disease is a multisystemic disease caused by a tickborne spirochete, Borrelia burgdorferi. Neuroborreliosis is characterized by intrathecal production of antibodies specific for the spirochete. This suggests that spirochetal infection of the central nervous system produces conditions that support the maturation of B lymphocytes to immunoglobulin-secreting cells. Interleukin 6 (IL-6) stimulates B cell differentiation into antibody-secreting cells. The present study was undertaken to determine whether B. burgdorferi can stimulate cells of central nervous system origin to secrete IL-6. C6 rat glioma cells cultured with spirochetes induced secretion of IL-6 activity. Peak stimulation was achieved at 24 h with 25 spirochetes per glioma cell. Glioma cells were also stimulated to produce IL-6 by interleukin 1 and tumor necrosis factor. That very few spirochetes are found in Lyme disease patients suggests that biologic amplification factors derived from the organism or the host, or both, are responsible for the pathogenesis of this disease. IL-6 can now be added to the growing list of such factors.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1908002     DOI: 10.1093/infdis/164.3.568

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  20 in total

1.  Induction of pro- and anti-inflammatory cytokines by Borrelia burgdorferi lipoproteins in monocytes is mediated by CD14.

Authors:  G H Giambartolomei; V A Dennis; B L Lasater; M T Philipp
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

Review 2.  Cordelia, Goneril and the febrile response.

Authors:  P A Mackowiak
Journal:  Trans Am Clin Climatol Assoc       Date:  1997

3.  Borrelia burgdorferi stimulates the production of interleukin-10 in peripheral blood mononuclear cells from uninfected humans and rhesus monkeys.

Authors:  G H Giambartolomei; V A Dennis; M T Philipp
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

4.  Normal human B lymphocytes and mononuclear cells respond to the mitogenic and cytokine-stimulatory activities of Borrelia burgdorferi and its lipoprotein OspA.

Authors:  K F Tai; Y Ma; J J Weis
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

5.  Nitric oxide production during murine Lyme disease: lack of involvement in host resistance or pathology.

Authors:  K P Seiler; Z Vavrin; E Eichwald; J B Hibbs; J J Weis
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

6.  Experimental immunization with Borrelia burgdorferi induces development of antibodies to gangliosides.

Authors:  J C Garcia-Monco; R J Seidman; J L Benach
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

7.  Prevalence of antibodies against Borrelia species in patients with unclassified uveitis in regions in which Lyme disease is endemic and nonendemic.

Authors:  K Kimura; E Isogai; H Isogai; T Nishikawa; T Masuzawa; K Yoshikawa; S Kotake; S Ohno; N Fujii
Journal:  Clin Diagn Lab Immunol       Date:  1995-01

8.  Borrelia burgdorferi outer surface lipoproteins OspA and OspB possess B-cell mitogenic and cytokine-stimulatory properties.

Authors:  Y Ma; J J Weis
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

Review 9.  The pathogenesis of lyme neuroborreliosis: from infection to inflammation.

Authors:  Tobias A Rupprecht; Uwe Koedel; Volker Fingerle; Hans-Walter Pfister
Journal:  Mol Med       Date:  2008 Mar-Apr       Impact factor: 6.354

10.  Possible role of glial cells in the onset and progression of Lyme neuroborreliosis.

Authors:  Geeta Ramesh; Juan T Borda; Amy Gill; Erin P Ribka; Lisa A Morici; Peter Mottram; Dale S Martin; Mary B Jacobs; Peter J Didier; Mario T Philipp
Journal:  J Neuroinflammation       Date:  2009-08-25       Impact factor: 9.587

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.